Detalles de la búsqueda
1.
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients.
Invest New Drugs
; 40(2): 314-321, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735674
2.
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.
Postgrad Med J
; 98(1163): 666-669, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062975
3.
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Endocr Pract
; 27(9): 886-893, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581327
4.
Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial.
Brain Behav Immun
; 88: 88-96, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32305573
5.
Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
Breast Cancer Res Treat
; 177(3): 549-559, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270763
6.
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy.
Postgrad Med J
; 95(1121): 155-161, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31004045
7.
The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong.
Postgrad Med J
; 93(1101): 395-400, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836933
8.
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.
Oncologist
; 19(9): 937-50, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117068
9.
Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer.
Stem Cells
; 31(9): 1992-2002, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857717
10.
Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong.
Hong Kong Med J
; 20(5): 401-6, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24948666
11.
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma.
Liver Cancer
; 13(1): 70-88, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38344450
12.
Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis.
Blood
; 117(6): 2044-53, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21084708
13.
Consensus Statements on Precision Oncology in the China Greater Bay Area.
JCO Precis Oncol
; 7: e2200649, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315266
14.
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits.
Cancer
; 118(21): 5293-301, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22517493
15.
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
Ann Surg Oncol
; 19(11): 3479-85, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22576067
16.
Integrating molecular mechanisms and clinical evidence in the management of trastuzumab resistant or refractory HER-2⺠metastatic breast cancer.
Oncologist
; 16(11): 1535-46, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22020213
17.
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).
Oncologist
; 16(12): 1721-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22135121
18.
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.
Adv Ther
; 38(12): 5752-5762, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699004
19.
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Adv Ther
; 38(7): 3900-3910, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34061324
20.
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC.
Cancers (Basel)
; 13(8)2021 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33919570